Real-world data on immune responses following heterologous prime-boost COVID-19 vaccination schedule with Pfizer and AstraZeneca vaccines in England

BACKGROUND: There are limited data on immune responses to heterologous COVID-19 immunisation schedules, especially following an extended ≥12-week interval between doses. METHODS: SARS-CoV-2 infection-naïve and previously-infected adults receiving ChAd-BNT (ChAdOx1 nCoV-19, AstraZeneca followed by BN...

Descripción completa

Detalles Bibliográficos
Autores principales: Westrop, Samantha J, Whitaker, Heather J, Powell, Annabel A, Power, Linda, Whillock, Corinne, Campbell, Helen, Simmons, Ruth, Warrener, Lenesha, Ramsay, Mary E, Ladhani, Shamez N, Brown, Kevin E, Amirthalingam, Gayatri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of The British Infection Association. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815191/
https://www.ncbi.nlm.nih.gov/pubmed/35131335
http://dx.doi.org/10.1016/j.jinf.2022.01.038

Ejemplares similares

Ejemplares similares